“Flower Power”: Controlled Inhalation of THC-Predominant Cannabis Flos Improves Health-Related Quality of Life and Symptoms of Chronic Pain and Anxiety in Eligible UK Patients

In November 2018, the UK’s Home Office established a legal route for eligible patients to be prescribed cannabis-based products for medicinal use in humans (CBPMs) as unlicensed medicines. These include liquid cannabis extracts for oral administration (“oils”) and dried flowers for inhalation (“flos...

Descripción completa

Detalles Bibliográficos
Autores principales: Moreno-Sanz, Guillermo, Madiedo, Alvaro, Lynskey, Michael, Brown, Matthew R. D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599241/
https://www.ncbi.nlm.nih.gov/pubmed/36289837
http://dx.doi.org/10.3390/biomedicines10102576

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599241/
https://www.ncbi.nlm.nih.gov/pubmed/36289837
http://dx.doi.org/10.3390/biomedicines10102576

Ejemplares similares